Director, CEO · Editas Medicine, Inc. · Common Stock
Side
SELL
Value
$12K
Shares
5,603
Price
$2.15
Executed
Dec 3, 2025
Disclosed
Dec 4, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 3 executedDec 4, 2025 disclosed
EDIT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
O'Neill Gilmore Neil filed this Form 4 reporting a open-market sale of EDIT on Dec 3, 2025. It became public on Dec 4, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO
O'Neill Gilmore Neilcik:0001742084
Issuer
Editas Medicine, Inc.cik:0001650664
Revision history · 0
No field has changed since this record was first ingested.
